Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06451016
Status:
COMPLETED
Last Update Posted:
2024-06-14
First Post:
2024-05-29
Brief Title:
Effects of Vitamin D Supplementation on Muscle Function Among Graves Disease Patients
Sponsor:
Frontier Medical and Dental College Abbotabad
Organization:
Frontier Medical and Dental College Abbotabad
Study Overview
Official Title:
Effects of Vitamin D Supplementation on Muscle Function Among Graves Disease Patients
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Introduction
A deficit in vitamin D may be involved in the development and presentation of Graves disease GD Lack of vitamin D and GD are linked to deteriorating quality of life QoL and weakening of the muscles Our goal was to look at the possible advantages of vitamin D supplementation for the improvement of thyroid-related QoL and muscle function in GD patients as well as the possible drawbacks of anti-thyroid drugs ATD
Methodology
A multicenter randomized controlled experiment with single-blinding was carried out with 48 patients who had been diagnosed with Graves illness The participants were split into two groups n24 patients in each group In addition to standard ATD Group A received either 70 μg 2800 IU of vitamin D daily or a corresponding placebo Investigator measured muscular function and isometric strength at baseline three and nine months
A deficit in vitamin D may be involved in the development and presentation of Graves disease GD Lack of vitamin D and GD are linked to deteriorating quality of life QoL and weakening of the muscles Our goal was to look at the possible advantages of vitamin D supplementation for the improvement of thyroid-related QoL and muscle function in GD patients as well as the possible drawbacks of anti-thyroid drugs ATD
Methodology
A multicenter randomized controlled experiment with single-blinding was carried out with 48 patients who had been diagnosed with Graves illness The participants were split into two groups n24 patients in each group In addition to standard ATD Group A received either 70 μg 2800 IU of vitamin D daily or a corresponding placebo Investigator measured muscular function and isometric strength at baseline three and nine months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None